legionnaires’ disease and iaq during covid 19
TRANSCRIPT
![Page 1: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/1.jpg)
Legionnaires’ Disease and IAQ During COVID‐19
Hung Cheung, MD, MPH, FACOEMApril 15, 2021
Cogency TEAM
![Page 2: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/2.jpg)
Agenda• Background• Habitat• Epidemiology/ Risk factors• Mode of Transmission/ Attack Rate• Clinical Presentation • Treatment• Prevention
Cogency TEAM
![Page 3: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/3.jpg)
Legionnaires’/ COVID‐19
What we know is incomplete!The current knowledge is evolving!
Cogency TEAM
![Page 4: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/4.jpg)
Path Through The Chaos
Cogency TEAM
![Page 5: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/5.jpg)
Types of Prevention
1. Primary prevention
2. Secondary prevention
3. Tertiary prevention
Cogency TEAM
![Page 6: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/6.jpg)
Agenda• Background• Habitat• Epidemiology/ Risk factors• Mode of Transmission/ Attack Rate• Clinical Presentation • Treatment• Prevention
Cogency TEAM
![Page 7: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/7.jpg)
Background
Cogency TEAM
![Page 8: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/8.jpg)
BackgroundLegionella bacteria
• Causes Legionellosis – Legionnaire’s disease (LD)– Pontiac Fever (PF)
• Gram‐negative bacteria• 60+ species, 70+ serogroups• Water (surface, ground) and
soil• Commonly found in our
water systems
SARS CoV2/ COVID‐19 virus• COVID‐19 – Caused by SARS
CoV2 virus• SARS CoV2 is a Corona virus• SARS CoV2 is an RNA virus• Other Corona viruses
– SARS 2003/ CFR15%– MERS 2012/ CFR 35%– Common cold (4: 229E, NL63,
OC43, HKU1)
Cogency TEAM
![Page 9: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/9.jpg)
American Legion convention 1976
Cogency TEAM
![Page 10: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/10.jpg)
Forensic Analytical Consulting ServicesCogency TEAM
• Wuhan, China
![Page 11: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/11.jpg)
BackgroundLegionella bacteria
• 221 pneumonia cases developed with multisystem involvement; 34 deaths in 1976
• Source unknown• Terrorism?• Press dubbed it “Board Street
Pneumonia” • Months of investigation –
identified bacteria as the causative agent in 1977
SARS CoV2/ COVID‐19 virus• Outbreak – Cases of
pneumonia with multisystem involvement in Wuhan, China in December 2019
• Source – wet market??• Animal => human?• Market ‐shut down/
disinfected• Continued cases not related to
the market• Hospital staff became infected• What Happened?
Cogency TEAM
![Page 12: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/12.jpg)
HabitatLegionella bacteria
• Waterborne• Grows best in slime,
sediment, or biofilms • Grows inside single cell
organisms e.g. amoebae, protozoa & slime mold
• Conditions: temperature, water stagnation, dead legs
• Legionellae can be isolated from natural waters
SARS CoV2/ COVID‐19 Virus• Enormous variety of animal
coronaviruses• Animal to animal
transmission• Corona virus often circulate
among camels, cats, bats• Can cause diarrhea in cows,
pigs and URI in chickens• Rapid mutations
Cogency TEAM
![Page 13: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/13.jpg)
Pathway Illustrating How Legionella/ Waterborne Pathogens Are Introduced to and Flow through Water Systems
Cogency TEAM
![Page 14: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/14.jpg)
Is your water sterile?Clean?
Cogency TEAM
![Page 15: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/15.jpg)
Habitat
Cogency TEAM
![Page 16: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/16.jpg)
Cogency TEAM
![Page 17: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/17.jpg)
Cogency TEAM
![Page 18: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/18.jpg)
Epidemiology
Cogency TEAM
![Page 19: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/19.jpg)
EpidemiologyLegionella bacteria
• 5.5x increase in reported cases from 2000‐2017
• ~7,500 cases reported in 2017• Significant underreporting is
estimated– Estimated 70,000 cases per
year (NASEM)• < 4% of cases are involved in
Outbreaks• Majority of cases are
“sporadic”• 10 to 35% mortality
SARS CoV2/ COVID‐19 Virus• China/ US Experience ‐ Initial
– 80% mild/ moderate to asymptomatic
– 15% severe disease– 5% critical disease– 2 – 4% mortality
• World– 138.02 million cases– 2,971,130 deaths (2.2%)
• US – 31,420,418 cases– 564,388 deaths (1.8%)
Cogency TEAM
![Page 20: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/20.jpg)
Risk Factors
Cogency TEAM
![Page 21: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/21.jpg)
Risk FactorsLegionella bacteria
• Smokers• Elderly (Age 50 or older)• Lung or kidney disease• Diabetes• Cancer• Weakened immune system
due to medications or disease
SARS CoV2/ COVID‐19 Virus• Obesity• Elderly (Age 60 & older)• Lung or kidney disease• Diabetes• Weakened Immune system• Liver disease• Heart disease• Minorities?
Cogency TEAM
![Page 22: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/22.jpg)
Mode of TransmissionLegionella bacteria
• Waterborne sources• Inhalation of aerosolized Legionella
contaminated water droplets • Aspiration or choking of drinking
Legionella contaminated water• Handling Legionella contaminated
soil• Surgical wounds treated with
Legionella contaminated potable water
• No person to person Transmission
SARS CoV2/ COVID‐19 Virus• Contagious ‐ Person to person• Main mode – infectious aerosol
droplets & micro‐sprays from talking
• Direct – cough, sneeze, droplet inhalation
• Contact from touching or being touched by infected individuals
• Not building systems or waterborne
Cogency TEAM
![Page 23: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/23.jpg)
Attack RateLegionella bacteriaWaterborne sources
• AR – 5% Legionnaires’• AR – 95% Pontiac Fever
SARS CoV2/ COVID‐19 VirusHuman reservoir/ source
• Incomplete knowledge• Diamond Princess >40%• SS G. Mortimer approx. 59%• Close contacts – 5%
– Household – 10 – 40%– Meals – 7%– HCW w/ PPE’s – 3%
• Casual/ grocery store – 0.6%
Cogency TEAM
![Page 24: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/24.jpg)
Clinical PresentationLegionnaires’
• Develops 2‐10/14 days after exposure to legionella bacteria with an avg. of 5‐6 days
• Symptoms (extrapulmonary) include:– Headache, muscle pain, chills– Fever that may be 104 F (40 C) or
higher– Cough, mucus and sometimes
blood– Shortness of breath, chest pain– Gastrointestinal symptoms, such as
nausea, vomiting and diarrhea– Confusion or other mental changes– Cardiovascular collapse and death
COVID‐19• Atypical & Critical Pneumonia• Develops 2‐14 days after
exposure to SARS CoV2 with avg. of 5 days
• Multi‐organ involvement– CNS/ neurological– Systemic– Skin– Kidneys– Respiratory– GI– Cardiovascular– Children ‐Multi‐organic
inflammatory
Cogency TEAM
![Page 25: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/25.jpg)
Clinical TreatmentLegionella bacteria
• Antibiotics – no documented antibiotic resistance
• Supportive care
SARS CoV2/ COVID‐19 Virus• Supportive care• FDA EUA – Remdisivir/
Devices• Promising
– Dexmethasone (steroid)– Convalescing plasma– IL 6 Inhibitor
• Trials– Treatments – 326– Vaccines ‐ 252
Cogency TEAM
![Page 26: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/26.jpg)
COVID‐19 – Principle for Response• Permanent Solution ‐ herd Immunity• Vaccine Development
Cogency TEAM
![Page 27: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/27.jpg)
PreventionLegionella bacteria
• Source to tap approach– Public& Professional
education– Best practices for public and
premise water (and water system) management
– Prompt notification of distribution disruptive events
– Best practices for investigations
– Research
SARS CoV2/ COVID‐19 Virus• Education• Herd immunity
– Vaccine• Effects of antivaxx
• NPI – prevent exposure• Testing• Contact tracing• Prophylaxis/ Treatment• Research
Cogency TEAM
![Page 28: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/28.jpg)
What Happens to the Indoor Environment During COVID‐19
Pandemic?What Happened to our Economy?
Cogency TEAM
![Page 29: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/29.jpg)
COVID‐19 Pandemic• Source to Tap Problems?–Water Utility• ST• LT
– Facilities• Idled Buildings• Risk Assessment• Maintaining & Recommissioning
Cogency TEAM
![Page 30: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/30.jpg)
Legionnaires’ Disease Reporting During COVID‐19 Pandemic
Cogency TEAM
![Page 31: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/31.jpg)
3,346 4,202
3,688
4,954 5,049 6,079 6,141
7,458
9,933 8,890
4,245
‐
2,000
4,000
6,000
8,000
10,000
12,000
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020*
Num
ber o
f Legionn
aires' Disease Cases
Year
United States Legionnaires' Disease CasesYear‐End Totals
* Total cases for 2020 are preliminary
![Page 32: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/32.jpg)
![Page 33: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/33.jpg)
![Page 34: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/34.jpg)
* Total cases for 2020 are preliminary
![Page 35: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/35.jpg)
Agenda• Background• Habitat• Epidemiology/ Risk factors• Mode of Transmission/ Attack Rate• Clinical Presentation • Treatment• Prevention
Cogency TEAM
![Page 36: Legionnaires’ Disease and IAQ During COVID 19](https://reader033.vdocument.in/reader033/viewer/2022052017/62867782c585545717255759/html5/thumbnails/36.jpg)
Types of Prevention
1. Primary prevention
2. Secondary prevention
3. Tertiary prevention
Cogency TEAM